Heart shield? diabetes drug tested to fight artery damage in psoriatic arthritis
NCT ID NCT07251556
First seen Dec 10, 2025 · Last updated May 22, 2026 · Updated 22 times
Summary
This study tests whether semaglutide, a drug used for diabetes, can slow the buildup of plaque in arteries of people with psoriatic arthritis who do not have diabetes. About 40 participants will receive either semaglutide or standard care for 24 weeks. Researchers will measure artery thickness and stiffness to see if the drug helps reduce heart disease risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.